Liang, J.; Fang, D.; Gumin, J.; Najem, H.; Sooreshjani, M.; Song, R.; Sabbagh, A.; Kong, L.-Y.; Duffy, J.; Balyasnikova, I.V.;
et al. A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Cancers 2023, 15, 1085.
https://doi.org/10.3390/cancers15041085
AMA Style
Liang J, Fang D, Gumin J, Najem H, Sooreshjani M, Song R, Sabbagh A, Kong L-Y, Duffy J, Balyasnikova IV,
et al. A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Cancers. 2023; 15(4):1085.
https://doi.org/10.3390/cancers15041085
Chicago/Turabian Style
Liang, Jiyong, Dexing Fang, Joy Gumin, Hinda Najem, Moloud Sooreshjani, Renduo Song, Aria Sabbagh, Ling-Yuan Kong, Joseph Duffy, Irina V. Balyasnikova,
and et al. 2023. "A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin" Cancers 15, no. 4: 1085.
https://doi.org/10.3390/cancers15041085
APA Style
Liang, J., Fang, D., Gumin, J., Najem, H., Sooreshjani, M., Song, R., Sabbagh, A., Kong, L.-Y., Duffy, J., Balyasnikova, I. V., Pollack, S. M., Puduvalli, V. K., & Heimberger, A. B.
(2023). A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Cancers, 15(4), 1085.
https://doi.org/10.3390/cancers15041085